InvestorsHub Logo
Followers 17
Posts 1850
Boards Moderated 0
Alias Born 01/07/2007

Re: None

Sunday, 01/02/2022 5:00:05 AM

Sunday, January 02, 2022 5:00:05 AM

Post# of 42924
EARLY LENZILUMAB TREATMENT OF COVID-19 PATIENTS USING C-REACTIVE PROTEIN AS A BIOMARKER IMPROVES EFFICACY: RESULTS FROM THE PHASE 3 LIVE-AIR TRIAL
https://www.medrxiv.org/content/10.1101/2021.12.30.21267140v1